Table 5.
Birth outcomes as predictors of continuous liver enzymes (log-transformed, within the normal range), Cardiovascular Risk in Young Finns Study
Model 1 | P for interaction | Model 2 | P for interaction | |||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
Unadjusted | Adjusted for age, sex, race, smoking, alcohol use, education, income, physical activity | |||||||
|
|
|||||||
βa | SE | P | β | SE | P | |||
γ-glutamate transferase (GGT) | ||||||||
Men | ||||||||
Small-for-gestational-age | 0.01 | 0.05 | 0.79 | 0.19 | 0.00 | 0.05 | 0.96 | 0.08 |
Large-for-gestational-age | −0.03 | 0.05 | 0.61 | 0.64 | −0.02 | 0.05 | 0.66 | 0.46 |
Preterm birth | 0.13 | 0.08 | 0.09 | 0.02 | 0.10 | 0.07 | 0.18 | 0.04 |
Women | ||||||||
Small-for-gestational-age | 0.08 | 0.00 | <0.01 | 0.09 | 0.03 | <0.01 | ||
Large-for-gestational-age | −0.05 | 0.03 | 0.06 | −0.06 | 0.03 | 0.03 | ||
Preterm birth | −0.06 | 0.04 | 0.15 | −0.06 | 0.04 | 0.17 | ||
Alanine transaminase (ALT) | ||||||||
Men | ||||||||
Small-for-gestational-age | 0.06 | 0.05 | 0.22 | 0.91 | 0.04 | 0.05 | 0.38 | 0.98 |
Large-for-gestational-age | −0.01 | 0.05 | 0.80 | 0.78 | −0.01 | 0.05 | 0.82 | 0.77 |
Preterm birth | 0.15 | 0.07 | 0.03 | <0.01 | 0.14 | 0.07 | 0.05 | <0.01 |
Women | ||||||||
Small-for-gestational-age | 0.05 | 0.03 | 0.06 | 0.05 | 0.03 | 0.09 | ||
Large-for-gestational-age | 0.00 | 0.03 | 0.93 | 0.01 | 0.03 | 0.71 | ||
Preterm birth | −0.07 | 0.04 | 0.10 | −0.06 | 0.04 | 0.13 | ||
Aspartate transaminase (AST) | ||||||||
Men | ||||||||
Small-for-gestational-age | 0.02 | 0.02 | 0.36 | 0.37 | 0.02 | 0.02 | 0.38 | 0.32 |
Large-for-gestational-age | −0.01 | 0.03 | 0.80 | 0.42 | −0.03 | 0.03 | 0.26 | 0.22 |
Preterm birth | 0.07 | 0.04 | 0.06 | 0.27 | −0.01 | 0.03 | 0.65 | 0.22 |
Women | ||||||||
Small-for-gestational-age | 0.05 | 0.02 | <0.01 | 0.05 | 0.02 | <0.01 | ||
Large-for-gestational-age | 0.02 | 0.02 | 0.26 | 0.02 | 0.02 | 0.23 | ||
Preterm birth | 0.02 | 0.03 | 0.51 | 0.01 | 0.03 | 0.69 | ||
Fatty liver index (FLI)a | ||||||||
Men | ||||||||
Small-for-gestational-age | 0.86 | 3.09 | 0.78 | 0.85 | −0.91 | 2.85 | 0.75 | 0.37 |
Large-for-gestational-age | 7.33 | 3.23 | 0.02 | 0.01 | 5.30 | 2.96 | 0.07 | 0.03 |
Preterm birth | 1.35 | 4.49 | 0.76 | 0.96 | 0.93 | 4.21 | 0.83 | 0.96 |
Women | ||||||||
Small-for-gestational-age | 1.56 | 2.01 | 0.44 | 2.03 | 1.96 | 0.30 | ||
Large-for-gestational-age | −2.33 | 1.98 | 0.24 | −1.90 | 1.98 | 0.34 | ||
Preterm birth | 1.61 | 3.10 | 0.60 | 1.86 | 3.12 | 0.55 | ||
|
||||||||
Model 3 | P for interaction | |||||||
| ||||||||
Previous +BMI | ||||||||
| ||||||||
β | SE | P | ||||||
| ||||||||
γ-glutamate transferase (GGT) | ||||||||
Men | ||||||||
Small-for-gestational-age | 0.02 | 0.05 | 0.68 | 0.14 | ||||
Large-for-gestational-age | −0.05 | 0.05 | 0.29 | 0.81 | ||||
Preterm birth | 0.12 | 0.07 | 0.07 | 0.01 | ||||
Women | ||||||||
Small-for-gestational-age | 0.09 | 0.03 | <0.01 | |||||
Large-for-gestational-age | −0.05 | 0.03 | 0.05 | |||||
Preterm birth | −0.06 | 0.04 | 0.11 | |||||
Alanine transaminase (ALT) | ||||||||
Men | ||||||||
Small-for-gestational-age | 0.06 | 0.04 | 0.17 | 0.94 | ||||
Large-for-gestational-age | −0.05 | 0.05 | 0.29 | 0.56 | ||||
Preterm birth | 0.16 | 0.07 | 0.02 | <0.01 | ||||
Women | ||||||||
Small-for-gestational-age | 0.06 | 0.03 | 0.04 | |||||
Large-for-gestational-age | 0.00 | 0.03 | 0.90 | |||||
Preterm birth | −0.07 | 0.04 | 0.07 | |||||
Aspartate transaminase (AST) | ||||||||
Men | ||||||||
Small-for-gestational-age | 0.03 | 0.02 | 0.26 | b | ||||
Large-for-gestational-age | −0.02 | 0.03 | 0.36 | 0.03 | ||||
Preterm birth | 0.08 | 0.04 | 0.04 | 0.96 | ||||
Women | ||||||||
Small-for-gestational-age | 0.05 | 0.02 | <0.01 | |||||
Large-for-gestational-age | 0.02 | 0.02 | 0.24 | |||||
Preterm birth | 0.01 | 0.03 | 0.65 | |||||
Fatty liver index (FLI) | BMI included in measurement |
Not log-transformed.
Interaction model failed to converge.